RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination

RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination

Introduction: Dyslipidemia-hypertension proves to be a major risk factor for cardiovascular diseases. In order to achieve better adherence and cost-effectiveness than free equivalent combination therapies, a fixed-dose combination therapy with telmisartan (TEL), rosuvastatin calcium (ROS) and amlodi...

Full description

Bibliographic Details
Main Authors: Rujuta P. Mistry, Chainesh Shah, Rakesh Jat
Format: Article
Language:English
Published: Pensoft Publishers 2022-02-01
Series:Folia Medica
Subjects:
accuracy
ICH guideline
mobile phase
precision
Online Access:https://foliamedica.bg/article/64339/download/pdf/

Internet

https://foliamedica.bg/article/64339/download/pdf/

Similar Items